{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:48:46Z","timestamp":1774622926019,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02243-6","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:45:45Z","timestamp":1771857945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of once daily and twice daily accelerated partial breast irradiation regimens in hormone receptor positive breast cancer: a single institution experience"],"prefix":"10.1186","volume":"28","author":[{"given":"Tanun","family":"Jitwatcharakomol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgeniya","family":"Gokun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra J.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariella","family":"Mestres-Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M.","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese Y.","family":"Andraos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin H.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia R.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Jose G.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavnesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha J.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin R.","family":"Jhawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"2243_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"G Collaborative","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019, Collaborative G, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(11)61629-2.","journal-title":"Lancet"},{"key":"2243_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.radonc.2011.01.010","volume":"100","author":"XS Qi","year":"2011","unstructured":"Qi XS, White J, Li XA. Is alpha\/beta for breast cancer really low? Radiother Oncol. 2011;100:282\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2011.01.010.","journal-title":"Radiother Oncol"},{"key":"2243_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1023\/a:1011136326943","volume":"12","author":"U Veronesi","year":"2001","unstructured":"Veronesi U, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997\u20131003. https:\/\/doi.org\/10.1023\/a:1011136326943.","journal-title":"Ann Oncol"},{"key":"2243_CR4","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","volume":"29","author":"ND Arvold","year":"2011","unstructured":"Arvold ND, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29:3885\u201391. https:\/\/doi.org\/10.1200\/JCO.2011.36.1105.","journal-title":"J Clin Oncol"},{"key":"2243_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","volume":"14","author":"SF Shaitelman","year":"2024","unstructured":"Shaitelman SF, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2024;14:112\u201332. https:\/\/doi.org\/10.1016\/j.prro.2023.11.001.","journal-title":"Pract Radiat Oncol"},{"key":"2243_CR6","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","volume":"394","author":"TJ Whelan","year":"2019","unstructured":"Whelan TJ, et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019;394:2165\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(19)32515-2.","journal-title":"Lancet"},{"key":"2243_CR7","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","volume":"394","author":"FA Vicini","year":"2019","unstructured":"Vicini FA, et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019;394:2155\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(19)32514-0.","journal-title":"Lancet"},{"key":"2243_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","volume":"51","author":"L Livi","year":"2015","unstructured":"Livi L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451\u201363. https:\/\/doi.org\/10.1016\/j.ejca.2014.12.013.","journal-title":"Eur J Cancer"},{"key":"2243_CR9","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/JCO.20.00650","volume":"38","author":"I Meattini","year":"2020","unstructured":"Meattini I, et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial. J Clin Oncol. 2020;38:4175\u201383. https:\/\/doi.org\/10.1200\/JCO.20.00650.","journal-title":"J Clin Oncol"},{"key":"2243_CR10","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.22.01485","volume":"41","author":"B Meduri","year":"2023","unstructured":"Meduri B, et al. Cosmetic results and side effects of accelerated partial-breast irradiation versus whole-breast irradiation for low-risk invasive carcinoma of the breast: the randomized phase III IRMA trial. J Clin Oncol. 2023;41:2201\u201310. https:\/\/doi.org\/10.1200\/JCO.22.01485.","journal-title":"J Clin Oncol"},{"key":"2243_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2025.04.011","author":"JG Bazan","year":"2025","unstructured":"Bazan JG, et al. Favorable rates of excellent or good cosmetic outcomes in patients treated with carefully planned accelerated partial breast irradiation delivered twice daily or once every other day. Pract Radiat Oncol. 2025. https:\/\/doi.org\/10.1016\/j.prro.2025.04.011.","journal-title":"Pract Radiat Oncol"},{"key":"2243_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9:1557\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759.","journal-title":"JAMA Oncol"},{"key":"2243_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, et al. Axillary surgery in breast cancer - primary results of the INSEMA trial. N Engl J Med. 2025;392:1051\u201364. https:\/\/doi.org\/10.1056\/NEJMoa2412063.","journal-title":"N Engl J Med"},{"key":"2243_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ijrobp.2010.01.059","volume":"77","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Yarnold JR. Reports of unexpected late side effects of accelerated partial breast irradiation\u2013radiobiological considerations. Int J Radiat Oncol Biol Phys. 2010;77:969\u201373. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.01.059.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2243_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ijrobp.2020.11.044","volume":"109","author":"RR Boutrus","year":"2021","unstructured":"Boutrus RR, et al. Once daily versus twice daily external beam accelerated partial breast irradiation: a randomized prospective study. Int J Radiation Oncology*Biology*Physics. 2021;109:1296\u2013300. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.044.","journal-title":"Int J Radiation Oncology*Biology*Physics"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02243-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02243-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02243-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:48:45Z","timestamp":1774619325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02243-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02243-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective, single-institution cohort study was conducted at The Ohio State University Wexner Medical Center in Columbus, Ohio, United States. Before starting the research, its protocol was approved by the Ohio State University Comprehensive Cancer Center Institutional Review Board (IRB Approval Number: 2024C0026). The study was conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments. The requirement for informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Sachin R. Jhawar reports receiving a research grant from Varian Medical Systems and serving as a consultant and advisory board member for Embiosys and Enlace Health. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}